Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other Non-Current Assets: 2020-2022

Historic Other Non-Current Assets for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2022 value amounting to $459,000.

  • Cullinan Therapeutics' Other Non-Current Assets fell 0.22% to $459,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $459,000, marking a year-over-year decrease of 0.22%. This contributed to the annual value of $459,000 for FY2022, which is 212.24% up from last year.
  • As of FY2022, Cullinan Therapeutics' Other Non-Current Assets stood at $459,000, which was up 212.24% from $147,000 recorded in FY2021.
  • In the past 5 years, Cullinan Therapeutics' Other Non-Current Assets registered a high of $2.3 million during FY2020, and its lowest value of $147,000 during FY2021.
  • Moreover, its 3-year median value for Other Non-Current Assets was $459,000 (2022), whereas its average is $968,667.
  • In the last 5 years, Cullinan Therapeutics' Other Non-Current Assets plummeted by 93.61% in 2021 and then skyrocketed by 212.24% in 2022.
  • Cullinan Therapeutics' Other Non-Current Assets (Yearly) stood at $2.3 million in 2020, then plummeted by 93.61% to $147,000 in 2021, then spiked by 212.24% to $459,000 in 2022.